Area of research
Genetics · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, Cancer-related Molecular Pathways, Genomic variations and chromosomal abnormalities, and BRCA gene mutations in cancer.
In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response
Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.
PubMed 2013cited by 102position: middle
Activity of the Fibroblast Growth Factor Receptor Inhibitors Dovitinib (TKI258) and NVP-BGJ398 in Human Endometrial Cancer Cells
FOXA1 represses the molecular phenotype of basal breast cancer cells